Human Oncology & Pathogenesis Program

The Renier Brentjens Lab

Share
Print

Research

Pictured: Renier J. Brentjens
Renier J. Brentjens, MD, PhD
Director, Cellular Therapeutics; Member in Human Oncology and Pathogenesis Program (HOPP)

Professor

My laboratory is focused on developing novel treatment approaches for certain leukemias and lymphomas utilizing the patient’s own immune system. Specifically this work involves the genetic manipulation of patients’ immune cells to recognize and kill their own cancer cells. This is a promising form of gene therapy.

In light of encouraging results in mouse studies, we are now testing this approach at Memorial Sloan Kettering in patients with chronic lymphocytic leukemia and acute lymphoblastic leukemia who are no longer responsive to chemotherapy. These highly innovative studies will hopefully result in a novel and successful treatment option for patients with certain forms of hematologic cancers.

The Renier Brentjens Lab

People

Pictured: Renier J. Brentjens

Renier J. Brentjens, MD, PhD

Director, Cellular Therapeutics; Member in Human Oncology and Pathogenesis Program (HOPP)

Professor

  • Physician-scientist Renier Brentjens develops novel immunotherapies for leukemias and lymphomas.
  • MD, PhD, The State University of New York at Buffalo, School of Medicine and Biomedical Sciences
brentjer@mskcc.org
Email Address
View physician profile
Physician profile

Members

Christina Bebernitz, Graduate Student
Christina Bebernitz

Graduate Student

Winson Cai

Graduate Student

Nan Chen

Senior Research Scientist

Kevin J. Curran, MD
Kevin J. Curran

Assistant Attending, Pediatric Bone Marrow Transplant Service

Anthony Daniyan, MD
Anthony Daniyan

Assitant Attending

Ruby Freeman

Research Technician

William Godfrey

Research Technician

Christopher Hackett

Fellow

Janneke Jaspers

Postdoctoral Research Fellow

Abdul Khan

Research Fellow

Jonathan Khan

Graduate Student

Xinghuo Li, Graduate Student
Xinghuo Li

Graduate Student

Gabriela Llaurador

Fellow

Andrea Lopez

Research Technician

Serena Mathew

Research Technician

Terence Purdon
Terence Purdon

Senior Research Assistant

Pictured: Eric Smith
Eric Smith

Assistant Attending

Dayenne van Leeuwen

Senior Research Technician

Analisa Wills
Analisa Wills

Project Coordinator

Sarah Yoo
Sarah Yoo

Laboratory Manager

Marjan Zaman

Graduate Student

Lab Alumni
Mauro Avanzi, MD, PhD
Mauro Avanzi

Research Associate

Peter Chang
Peter Chang

Graduate Student

Dylan Drakes
Dylan Drakes

Graduate Student

Mythili Koneru, MD, PhD
Mythili Koneru

Medical Oncology Fellow

Amy  Kong
Amy Kong

Research Study Assistant

Nicholas F. Kuhn, BS, MS, Graduate Student
Nicholas F. Kuhn

Graduate Student

Stephen Lee

Medical Oncology Fellow

Christina Macaulay
Christina Macaulay

Research Study Assistant

Reed Masakayan
Reed Masakayan

Senior Research Technician

Manjusha Namuduri

Pediatric Hematology-Oncology Fellow

Hollie Pegram, PhD
Hollie Pegram

Senior Research Scientist

Swati Pendharkar, MD
Swati Pendharkar

Research Fellow

Sarwish Rafiq, PhD
Sarwish Rafiq

Senior Research Scientist

Liora Schultz
Liora Schultz

Medical Oncology Fellow

Mette Staehr

Senior Research Technician

Dinali Wijewarnasuriya, Graduate Student
Dinali Wijewarnasuriya

Graduate Student

Oladapo Yeku, Medical Oncology Fellow
Oladapo Yeku

Medical Oncology Fellow

Lab Affilations

Achievements

  • STRAP Supplemental Award, National Cancer Institute (2010-2013)
  • William Lawrence Blanche Hughes Foundation Grant (2011-2016)
  • CLL Global Research Foundation Grant (2009-2014) R01 Award, National Institutes of Health (2009-2014)
  • Experimental Therapeutics Center Program Project Grant, National Institutes of Health (2009-2014)
  • Geoffrey Beene Cancer Research Center Fund Award (2007-2009)
Read more
  • Experimental Therapeutics Center Program Project Grant, National Institutes of HEalth (2005-2010)
  • Clinical Investigator Award, Damon Runyon Foundation (2006-2011)

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Renier J. Brentjens discloses the following relationships and financial interests:

  • American Institute of Biological Sciences
    Provision of Services
  • Celgene
    Provision of Services
  • Emerson Collective
    Provision of Services
  • Gracell Biotechnologies Ltd.
    Provision of Services
  • Juno Therapeutics
    Intellectual Property Rights; Provision of Services (uncompensated)

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures